Quantitative magnetic resonance imaging biomarkers in oncological clinical trials: Current techniques and standardization challenges
Radiological imaging plays an important role in oncological trials to provide imaging biomarkers for disease staging, stratifying patients, defining dose setting, and evaluating the safety and efficacy of new candidate drugs and innovative treatment. This paper reviews the techniques of most commonl...
Main Authors: | Jie Deng, Yi Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2017-03-01
|
Series: | Chronic Diseases and Translational Medicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2095882X16301347 |
Similar Items
-
Diffusion-weighted magnetic resonance imaging: biomarker for treatment response in oncology
by: Maria Luiza Testa, et al.
Published: (2013-06-01) -
Magnetic Resonance Imaging for Translational Research in Oncology
by: Maria Felicia Fiordelisi, et al.
Published: (2019-11-01) -
Quantitative Analysis of Dynamic Contrast-Enhanced and Diffusion-Weighted Magnetic Resonance Imaging for Oncology in R
by: Volker J. Schmid, et al.
Published: (2011-10-01) -
Functional magnetic resonance imaging in oncology: state of the art
by: Marcos Duarte Guimaraes, et al.
Published: (2014-04-01) -
Quantitative magnetic resonance imaging with magnetic nanoparticles
Published: ()